Man sieht genau Verlust Stevioside-Segment 2012 2.479.841 $ eindeutig wieder rückläufig im Vergleich zu FJ 2011 3.517.236 $ während die Med-Sparte trotz einer Million $ mehr Revenues als im Vorjahr immernoch 1.213.699 $ Verlust gemacht hat (Vorjahr 1.339.415 $ Verlust) Corporate and Other expenses ordne ich mal pauschal 50:50 je 360.000 $ an Kosten 2012 zu.
von den 4.395.714 $ Gesamtverlust ordne ich also ca 1.600.000 $ der Med.-sparte zu.
Fazit für mich die chinesische Spedizinsparte kann ruhig weg und die Stevia-Sparte kann wie geplant die Produktion verdoppeln und somit auch den Umsatz.
For the Year Ended April 30, 2012 | | | | Chinese Medicine | | | Stevioside | | | Corporate and Other | | | Consolidated | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loss on disposal of property and equipment | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loss from continuing operations before income taxes and noncontrolling interest | | | | | | | | | | | | | | | | |
SUNWIN STEVIA INTERNATIONAL, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS YEARS ENDED APRIL 30, 2012 AND 2011 For the Year Ended April 30, 2011 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (Gain) loss on disposal of property and equipment | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loss from continuing operations before income taxes and noncontrolling interest | | | | | | | | | | | | | | | | |
NOTE 14 – CONCENTRATIONS AND CREDIT RISK |